Ronald George
Rheumatology · Wilmington, NCNPI 1265657894
Payments from drug & device makers
Across 1,463 payments — averaging $703.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$388K
- Sun Pharmaceutical Industries Inc.$263K
- Eli Lilly$251K
- AbbVie$99K
- E.r. Squibb & Sons, L.L.C.$13K
- Gilead$5K
- plus $11K from 31 others
Across 2 payments — averaging $138.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$276
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 386 | $387,605 |
| Sun Pharmaceutical Industries Inc. | 174 | $263,036 |
| Eli Lilly | 22 | $251,151 |
| AbbVie | 199 | $98,549 |
| E.r. Squibb & Sons, L.L.C. | 22 | $13,171 |
| Gilead | 2 | $5,000 |
| UCB, Inc. | 128 | $2,000 |
| Pfizer | 210 | $1,821 |
| Biogen | 1 | $1,185 |
| Johnson & Johnson(2 entities) | 46 | $740 |
| GSK | 41 | $686 |
| Lilly USA, LLC | 38 | $605 |
| AstraZeneca(2 entities) | 33 | $605 |
| Novartis | 27 | $538 |
| Genentech USA, Inc. | 27 | $372 |
| Radius Health, Inc. | 13 | $278 |
| Fresenius Kabi USA, LLC | 11 | $274 |
| Aurinia Pharma U.S., Inc. | 9 | $153 |
| Mallinckrodt Hospital Products Inc. | 7 | $142 |
| Regeneron Healthcare Solutions, Inc. | 13 | $136 |
| Bristol Myers Squibb | 6 | $127 |
| Sobi, Inc | 5 | $126 |
| Sanofi-aventis U.S. LLC | 2 | $107 |
| Antares Pharma, Inc. | 6 | $105 |
| Boehringer Ingelheim | 5 | $103 |
| Sanofi | 5 | $98 |
| Organon | 4 | $88 |
| Mallinckrodt Enterprises LLC | 3 | $81 |
| Medexus Pharma, Inc. | 4 | $49 |
| Hikma Pharmaceuticals USA | 3 | $45 |
| Lundbeck LLC | 2 | $45 |
| Sandoz | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Acorda Therapeutics, Inc | 2 | $24 |
| Grifols USA, LLC | 1 | $19 |
| Neurelis, Inc. | 1 | $12 |
How this compares
$1,029,173 in reported general payments places this provider in the 95th percentile of 210 rheumatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Wilmington
- Wendy SimmonsWilmington$462K
- Mark HarrisWilmington$101K
- John HarshbargerWilmington$20K
- Laura SchanbergDurham$6.9M
- Rakesh PatelSalisbury$4M
- Jane BoxCharlotte$3.9M
- Gordon LamCharlotte$3.5M
- David SnowDelco$3.4M
- Alireza NamiCharlotte$3.1M
- Tauseef SyedGreensboro$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.